1. Home
  2. FOLD vs GEF Comparison

FOLD vs GEF Comparison

Compare FOLD & GEF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FOLD
  • GEF
  • Stock Information
  • Founded
  • FOLD 2002
  • GEF 1877
  • Country
  • FOLD United States
  • GEF United States
  • Employees
  • FOLD N/A
  • GEF N/A
  • Industry
  • FOLD Biotechnology: Pharmaceutical Preparations
  • GEF
  • Sector
  • FOLD Health Care
  • GEF
  • Exchange
  • FOLD Nasdaq
  • GEF Nasdaq
  • Market Cap
  • FOLD 2.9B
  • GEF 3.2B
  • IPO Year
  • FOLD 2007
  • GEF N/A
  • Fundamental
  • Price
  • FOLD $6.83
  • GEF $51.32
  • Analyst Decision
  • FOLD Strong Buy
  • GEF Buy
  • Analyst Count
  • FOLD 9
  • GEF 7
  • Target Price
  • FOLD $17.00
  • GEF $75.67
  • AVG Volume (30 Days)
  • FOLD 3.9M
  • GEF 174.2K
  • Earning Date
  • FOLD 05-08-2025
  • GEF 06-04-2025
  • Dividend Yield
  • FOLD N/A
  • GEF 4.21%
  • EPS Growth
  • FOLD N/A
  • GEF N/A
  • EPS
  • FOLD N/A
  • GEF 4.43
  • Revenue
  • FOLD $528,294,999.00
  • GEF $5,508,100,000.00
  • Revenue This Year
  • FOLD $21.83
  • GEF N/A
  • Revenue Next Year
  • FOLD $22.16
  • GEF $12.10
  • P/E Ratio
  • FOLD N/A
  • GEF $11.57
  • Revenue Growth
  • FOLD 32.29
  • GEF 6.88
  • 52 Week Low
  • FOLD $6.20
  • GEF $48.23
  • 52 Week High
  • FOLD $12.65
  • GEF $73.16
  • Technical
  • Relative Strength Index (RSI)
  • FOLD 32.01
  • GEF 41.13
  • Support Level
  • FOLD $6.20
  • GEF $50.24
  • Resistance Level
  • FOLD $6.95
  • GEF $53.03
  • Average True Range (ATR)
  • FOLD 0.43
  • GEF 2.14
  • MACD
  • FOLD -0.04
  • GEF -0.02
  • Stochastic Oscillator
  • FOLD 29.86
  • GEF 41.31

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.

About GEF Greif Inc.

Greif Inc is a producer of industrial packaging products and services with manufacturing facilities located in many countries. It offers a comprehensive line of rigid industrial packaging products, such as steel, fiber, and plastic drums, rigid intermediate bulk containers, closure systems for industrial packaging products, transit protection products, water bottles and remanufactured and reconditioned industrial containers, and services, such as container life cycle management, blending, filling, logistics, warehousing, and other packaging services. The company operates in three reportable business segments including Global Industrial Packaging, Paper Packaging and Services, and Land Management. It operates in USA, Europe, Middle East, Africa and Asia and Other Americas.

Share on Social Networks: